Tag: Chelsea Pratt

December 10, 2018

Genetics Outlook 2019: CRISPR Technology Advances

With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
December 3, 2018

4 Gene Therapy Companies to Watch

What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
November 13, 2018

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
October 14, 2018

10 Drugs Going Off Patent in 2018

A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 4, 2018

6 ASX Medical Device Stocks

These companies are engaged in a wide range of compelling research around everything from respiratory devices and inflatable tissue to...